Lesson series

Elective: Biologics

The purpose of this module, is to familiarise participants with the complex manufacture and control of biologics / proteins and the interpretation of Annex 1 and Annex 2 of the cGMPs. The module will cover the control of key production process steps, unit operations for a selected production process, in-process checks at different stages of processing and sources of contamination and controls to prevent contamination 
Write your awesome label here.

5 Topics

Across 3 hours of online content

2 Case Studies

Direct from industry

4 Quizzes

Check your knowledge

1 Assessment

Complete the course

1 Q&A Webinar

Live session with a CBE Expert
Normal text with icon

Supplementary Learning Materials

Videos, resources, useful reading, links and examples

Who is this course for?

This course is designed for those new to industry or looking to start a new career in a GMP environment. It covers fundamental concepts of GMP and is delivered in an online, virtual environment. 

New Starts & Entry Level Employees

Boost your confidence in core GMP knowledge

Students & Recent Graduates

Kickstart your career in industry and gain practical skills

Existing Employees

Update your knowledge and refresh your skills

Meet your trainers for this course

Our trainers have decades of industry knowledge, technical expertise and practical experience across all aspects of the biopharmaceutical sector. 

Steve Williams

Course Trainer

With over 45 years experience in the Biotechnology, Pharmaceutical and Medical Device industries, Steve provides strategic solutions to regulatory and compliance challenges, along with advanced training courses. He has over 25 years consulting experience in GMPs, Compliance, Auditing, Training and Quality Systems to all international standards.

Jeff Davies

Course Trainer

With more than 30 years of leadership across the biopharmaceutical industry, Jeff was CSL’s Executive Vice President and GM Asia Pacific. He also had oversight of plasma products, influenza vaccines, anti-venoms, in licensed vaccines and pharmaceuticals as well as the diagnostic product business.

Pages

Policy Pages

Follow us on LinkedIn

Copyright © CBE 2025